Commissioning Criteria Policy for the use of therapeutic Immunoglobulin (Ig) in England (2021)

Document first published:
Page updated:
Topic:
Publication type:

Documents relating to the updates Commissioning Criteria Policy for the use of therapeutic Immunoglobulin (Ig) in England.

Summary

Update to the Commissioning Criteria Policy for the use of therapeutic immunoglobulin (Ig) 2021

Summary

Outline of the criteria required by the the Clinical Priorities Advisory Group (CPAG) for the commissioning criteria policy for the use of therapeutic Immunoglobulin.

Summary

A copy of the Equality and Health Inequalities Impact Assessment (EHIA) form.

Summary

Changes made to the clinical commissioning policy on therapeutic Immunoglobulin as a result of stakeholder testing.